4th Annual Paragraph IV Disputes Master Symposium

Topics

• Ethics of Paragraph IV Practice: New Developments Impacting Professional Responsibility in the Hatch-Waxman Arena
• Overcoming Obviousness in the Hatch Waxman Space: Prior Art, Obviousness, and Obvious-Type Double Patenting
   

Event Details

American Conference Institute's 4th Annual Paragraph IV Disputes Master Symposium is the “place to be” for the “who’s who” of litigators in the brand-name and generic pharmaceutical space.  Attendees will hear from industry leaders in the space, and will have the opportunity to connect with their peers to discuss the challenges that arise in the various regions of the Hatch Waxman arena.

• "Overcoming Obviousness in the Hatch Waxman Space: Prior Art, Obviousness, and Obvious-Type Double Patenting" will discuss addressing obviousness of pharmaceutical patents at the PTAB, evaluating recent case law, and more.
• "Ethics of Paragraph IV Practice: New Developments Impacting Professional Responsibility in the Hatch-Waxman Arena" will discuss the ethical implications of Halo v. Pulse and Stryker v. Zimmer, as well as escaping a willfulness finding.